Use of inhaled and oral glucocorticoids, severity of inflammatory disease and risk of hip/femur fracture: a population‐based case–control study
F De Vries, S Pouwels, JWJ Lammers… - Journal of internal …, 2007 - Wiley Online Library
Background. Patients using higher dosages of inhaled or oral glucocorticoids (GCs) have an
increased risk of hip/femur fractures. The role of the underlying disease in the aetiology of …
increased risk of hip/femur fractures. The role of the underlying disease in the aetiology of …
Use of inhaled and oral glucocorticoids, severity of inflammatory disease and risk of hip/femur fracture: a population-based case-control study
F de Vries, S Pouwels… - Journal of internal …, 2007 - pubmed.ncbi.nlm.nih.gov
Background Patients using higher dosages of inhaled or oral glucocorticoids (GCs) have an
increased risk of hip/femur fractures. The role of the underlying disease in the aetiology of …
increased risk of hip/femur fractures. The role of the underlying disease in the aetiology of …
Use of inhaled and oral glucocorticoids, severity of inflammatory disease and risk of hip/femur fracture: a population-based case-control study.
F de Vries, S Pouwels… - Journal of Internal …, 2007 - cris.maastrichtuniversity.nl
Background: Patients using higher dosages of inhaled or oral glucocorticoids (GCs) have an
increased risk of hip/femur fractures. The role of the underlying disease in the aetiology of …
increased risk of hip/femur fractures. The role of the underlying disease in the aetiology of …
Use of inhaled and oral glucocorticoids, severity of inflammatory disease and risk of hip/femur fracture: a population-based case-control study
F de Vries, S Pouwels, JWJ Lammers… - Journal of Internal …, 2007 - eprints.soton.ac.uk
BACKGROUND: Patients using higher dosages of inhaled or oral glucocorticoids (GCs)
have an increased risk of hip/femur fractures. The role of the underlying disease in the …
have an increased risk of hip/femur fractures. The role of the underlying disease in the …
Use of inhaled and oral glucocorticoids, severity of inflammatory disease and risk of hip/femur fracture: a population-based case-control study.
F Vries, S Pouwels, JWJ Lammers, HGM Leufkens… - 2007 - cabidigitallibrary.org
Background. Patients using higher dosages of inhaled or oral glucocorticoids (GCs) have an
increased risk of hip/femur fractures. The role of the underlying disease in the aetiology of …
increased risk of hip/femur fractures. The role of the underlying disease in the aetiology of …
Use of inhaled and oral glucocorticoids, severity of inflammatory disease and risk of hip/femur fracture: a population-based case–control study.
F de Vries, S Pouwels, JWJ Lammers… - Journal of Internal …, 2007 - search.ebscohost.com
Background. Patients using higher dosages of inhaled or oral glucocorticoids (GCs) have an
increased risk of hip/femur fractures. The role of the underlying disease in the aetiology of …
increased risk of hip/femur fractures. The role of the underlying disease in the aetiology of …
Use of inhaled and oral glucocorticoids, severity of inflammatory disease and risk of hip/femur fracture: a population-based case-control study.
T Van Staa, F de Vries, S Pouwels… - Journal of Internal …, 2007 - research.manchester.ac.uk
BACKGROUND: Patients using higher dosages of inhaled or oral glucocorticoids (GCs)
have an increased risk of hip/femur fractures. The role of the underlying disease in the …
have an increased risk of hip/femur fractures. The role of the underlying disease in the …
[引用][C] Use of inhaled and oral glucocorticoids, severity of inflammatory disease and risk of hipfemur fracture: a population-based case-control study.
P deVries F - J Intern Med, 2007 - cir.nii.ac.jp
Use of inhaled and oral glucocorticoids, severity of inflammatory disease and risk of
hipfemur fracture: a population-based case-control study. | CiNii Research CiNii 国立情報学 …
hipfemur fracture: a population-based case-control study. | CiNii Research CiNii 国立情報学 …
Use of inhaled and oral glucocorticoids, severity of inflammatory disease and risk of hip/femur fracture: a population-based case-control study.
F de Vries, S Pouwels, JW Lammers… - Journal of Internal …, 2007 - europepmc.org
Background Patients using higher dosages of inhaled or oral glucocorticoids (GCs) have an
increased risk of hip/femur fractures. The role of the underlying disease in the aetiology of …
increased risk of hip/femur fractures. The role of the underlying disease in the aetiology of …
Use of inhaled and oral glucocorticoids, severity of inflammatory disease and risk of hip/femur fracture: a population-based case-control study.
F de Vries, S Pouwels, J Lammers… - Journal of internal …, 2007 - ora4-prd.bodleian.ox.ac.uk
BACKGROUND: Patients using higher dosages of inhaled or oral glucocorticoids (GCs)
have an increased risk of hip/femur fractures. The role of the underlying disease in the …
have an increased risk of hip/femur fractures. The role of the underlying disease in the …